Tizanidine
- Product NDC
- 68788-6365
- 11-digit product format
- 687886365
- Labeler code
- 68788
- Product ID
- 68788-6365_f142e329-f086-4001-aabf-076fd678010f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA076416
- Marketing category
- ANDA
- Marketing start
- 2016-03-16
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-6365-2 | 68788636502 | 20 TABLET in 1 BOTTLE (68788-6365-2) | 20 tablet | 2019-04-04 | 0000-00-00 | No | No | Current |
| 68788-6365-3 | 68788636503 | 30 TABLET in 1 BOTTLE (68788-6365-3) | 30 tablet | 2016-03-16 | 0000-00-00 | No | No | Current |
| 68788-6365-6 | 68788636506 | 60 TABLET in 1 BOTTLE (68788-6365-6) | 60 tablet | 2016-03-16 | 0000-00-00 | No | No | Current |
| 68788-6365-8 | 68788636508 | 120 TABLET in 1 BOTTLE (68788-6365-8) | 120 tablet | 2016-03-16 | 0000-00-00 | No | No | Current |
| 68788-6365-9 | 68788636509 | 90 TABLET in 1 BOTTLE (68788-6365-9) | 90 tablet | 2016-03-16 | 0000-00-00 | No | No | Current |